DoP rejects Aristo Pharma’s review application for its multivitamin tablets: Gireesh Babu, New Delhi Friday, November 8, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals ...
Compared with the general population, patients with erythropoietic protoporphyria have notably lower bone mineral density, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback